Aims The aim of the present paper was to provide an up‐to‐date view on epidemiology and
risk factors of heart failure (HF) development after myocardial infarction. Methods and results …

Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Heart failure (HF) is a frequent consequence of myocardial infarction (MI). Identification of
the precise, time-dependent composition of inflammatory cells may provide clues for the …

ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of
coronary artery disease and is associated with great morbidity and mortality. A complete …

Abstract Sodium glucose cotransporter-2 (SGLT2) inhibitors improve cardiorenal outcomes
in patients with type 2 diabetes mellitus, chronic kidney disease, and chronic heart failure …

Myocardial infarction (MI) remains the most common cause of heart failure (HF) worldwide.
For almost 50 years HF has been recognised as a determinant of adverse prognosis after …

Background: For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if β-
blockers are associated with reduced mortality. Objectives: The goal of this study was to …

Background The role of lifestyle physical activity (PA) trajectories in the mortality risk of
patients with coronary heart disease (CHD) remains unclear. Objectives The purpose of this …

Acute coronary syndrome (ACS) is frequently complicated by evidence of heart failure (HF).
Those at highest risk for acute decompensated HF in the setting of ACS (ACS-HF) are older …